About Aegerion Pharmaceuticals Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com. Forward-Looking Statements This press release contains forward-looking statements, including statements regarding the clinical development and regulatory pathway for approval of lomitapide in Japan and the potential for lomitapide as a treatment for HoFH.